Upregulation of GRP78 and GRP94 and Its Function in Chemotherapy Resistance to VP-16 in Human Lung Cancer Cell Line SK-MES-1

REFERENCES

• Parkin D. M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2)74–108
   PubMed Web of Science ®Google Scholar
• Lee A. S. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 2001; 26(8)504–510
   PubMed Web of Science ®Google Scholar
• Yong F., Amy S. L. Glucose regulated protein in cancer progression, drug resistance and immunotherapy. Cancer Biol. Ther. 2006; 5(7)741–744
   PubMed Web of Science ®Google Scholar
• Mazzarella R. A., Green M. ERp99, an abundant, conserved glycoprotein of the endoplasmic reticulum, is homologous to 90 kDa heat shockprotein (hsp90) and the 94 kDa glucose-regulated protein (GRP94). J Biol Chem 1987; 262(18)8875–8879
   PubMed Web of Science ®Google Scholar
• Yang Y., Li Z. Roles of heat shock protein grp96 in the ER quality control: redundant or unique function?. Mol Cells 2005; 20(2)173–182
   PubMed Web of Science ®Google Scholar
• Lee A. S. Mammalian stress response: induction of the glucose-regulated protein family. Curr Opin Cell Biol 1992; 4(2)267–273
   PubMedGoogle Scholar
• Little E., Ramakrishnan M., Roy B., Gazit G., Lee A. S. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Exp 1994; 4(1)1–18
   PubMedGoogle Scholar
• Rupert L., Feith M., Rüdiger Siewert J., Wester H.-J., Hoefler H. Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. BMC Cancer 2008; 8: 70
   PubMedGoogle Scholar
• Wang Q., He Z., Zhang J., Wang Y., Wang T., Tong S., Wang L., Wang S., Chen Y. Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance. Cancer Detect. Prevent. 2005; 29(6)544–551
   PubMedGoogle Scholar
• Jianze L., Lee A. S. Stress induction of GRP78/Bip and its role in cancer. Curr Mol Med 2006; 6(1)45–50
   PubMed Web of Science ®Google Scholar
• Koumenis C. ER stress, hypoxia tolerance, and tumor progression. Curr Mol Med 2006; 6(1)55–69
   PubMed Web of Science ®Google Scholar
• Sutherland R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 1988; 240: 177–184
   PubMed Web of Science ®Google Scholar
• Haas I. G., Wabl M. Immunoglobulin heavy chain binding protein. Nature 1983; 306: 387–389
   PubMed Web of Science ®Google Scholar
• Gazit G., Lu J., Lee A. S. De-regulation of GRP stress protein expression in human breast cancer cell lines. Breast Cancer Res Treat 1999; 54(2)135–146
   PubMed Web of Science ®Google Scholar
• Li L. J., Li X., Ferrario A., Rucker N., Liu E. S., Wong S., Gomer C. J., Lee A. S. Establishment of a Chinese hamster ovary cell line that expresses grp78 antisense transcripts and suppresses A23187 induction of both GRP78 and GRP94. J Cell Physiol 1992; 153(3)575–582
   PubMed Web of Science ®Google Scholar
• Jamora C., Dennert G., Lee A. S. Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc Natl Acad Sci USA 1996; 93(15)7690–7694
   PubMed Web of Science ®Google Scholar
• Pyrko P., Shonthal A. H., Hofman F. M., Chen T. C., Lee A. S. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res 2007; 16(20)9809–9816, Oct 15
   Google Scholar
• Reddy R.K., Lu J., Lee A. S. The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca2+-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis. J Biol Chem 1999; 274(40)28476–28483
   PubMed Web of Science ®Google Scholar
• Rao R.V., Peel A., Logvinova A., del Rio , G., Hermel E., Yokota T., Goldsmith P. C., Ellerby L. M., Ellerby H. M., Bredesen D. E. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 2002; 514(2–3)122–128
   PubMed Web of Science ®Google Scholar
• Reddy R. K., Mao C., Baumeister P., Austin R. C., Kaufman R. J., Lee A. S. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 2003; 278(23)20915–20924
   PubMed Web of Science ®Google Scholar
• Lee A. S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 2007; 67(8)3496–3499, Apr 15
   PubMed Web of Science ®Google Scholar
• Wang Q., Wang T., Wang Y., Wang W., Wang Y., Hu X., Shao S., Zhang J., Suo Z. VP-16 resistance in the NCI-H460 human lung cancer cell line is significantly associated with glucose-regulated protein78 (GRP78) induction. Anticancer Res 2007; 27(4B)2359–2364
   PubMed Web of Science ®Google Scholar
• Pirozynski M. 100 years of lung cancer. Respir Med 2006; 100(12)2073–2084, Dec
   PubMed Web of Science ®Google Scholar
• Reiko I., Masaomi N., Hiroshi O., Hiroshi U., Yasuko K., Kiyokazu N., Ogawa S., Kurokawa K., Couser W. G., Miyata T. Involvement of endoplasmic reticulum (ER) stress in podocyte injury induced by excessive protein accumulation. Kidney Int 2005; 68(6)2639–2650
   PubMed Web of Science ®Google Scholar
• Li W.W., Alexandre S., Cao X., Lee A. S. Transactivation of the grp78 promoter by Ca2+ depletion. A comparative analysis with A23187 and the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin. J Biol Chem 1993; 268(16)12003–12009
   PubMed Web of Science ®Google Scholar
• Lee A. S. Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. Trends Biochem Sci 1987; 12: 20–23
   Web of Science ®Google Scholar
• Chatterjee S., Cheng M. F., Berger R. B., Berger S. J., Berger N. A. Effect of inhibitors of poly (ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide. Cancer Res 1995; 55(4)868–873
   PubMed Web of Science ®Google Scholar
• Dong D.Z., Ko B., Baumeister P., Swenson S., Costa F., Markland F., Stiles C., Patterson J. B., Bates S. E., Lee A. S. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res 2005; 65(13)5785–5791
   PubMed Web of Science ®Google Scholar
• Kubota H., Suzuki T., Lu J., Takahashi S., Sugita K., Sekiya S., Suzuki N. Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays in cervical cancer cell lines. Int J Radiat Biol 2005; 81(9)701–709
   PubMed Web of Science ®Google Scholar
• Herzog T.J. Recurrent ovarian cancer: how important is it to treat to disease progression?. Clin Cancer Res 2004; 15(10)7439–7449
   Google Scholar
• Hande KR. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 1998; 34(10)1514–1521
   PubMed Web of Science ®Google Scholar
• Gosky D., Chatterjee S. Down-regulation of topoisomerase II is caused by up-regulation of GRP78. Biochem Biophys Res Commun 2003; 300(2)327–332
   PubMed Web of Science ®Google Scholar
• Rao R. V., Hermel E., Castro-Obregon S., del Rio G., Ellerby L. M., Ellerby H. M., Bredesen D. E. Coupling endoplasmic reticulum stress to the cell death program: mechanism of caspase activation. J Biol Chem 2001; 276(36)33869–33874
   PubMed Web of Science ®Google Scholar
• Fu Y., Li J., Lee A. S. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen-starvation induced apoptosis. Cancer Res 2007; 67(8)3734–3740
   PubMed Web of Science ®Google Scholar
• Brewer J.W., Hendershot L. M., Sherr C. J., Diehl J. A. Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. Proc Natl Acad Sci USA 1999; 96(15)8505–8510, Jul 2
   PubMed Web of Science ®Google Scholar
• Tomida A., Tsuruo T. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des 1999; 14(2)169–177
   PubMedGoogle Scholar
• Ying-Yan W., Tao W., Xin L., Hong-Wei G., Bing-Cheng L., Qi W. The analysis of chemotherapy resistance in human lung cancer cell line with microchip-based system. Biomed Microdevices 2008; 10(3)429–435
   PubMed Web of Science ®Google Scholar